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Abstract
Staphylococcus aureus is a metabolically versatile human pathogen, causing
disease in many areas of the body. Its versatility can be attributed to the fact that it
utilizes a variety of tools to adapt to many different environments, including toxins to
scavenge from the host and multiple transporters to compete for its preferred carbon
sources. S. aureus can also survive in harsh conditions through biofilm development,
which are notoriously recalcitrant to antibiotics and immune defenses. Biofilms exhibit
marked heterogeneity, with division of labor for production of matrix components and
differential gene expression among various niches within the biofilm.
In this study, we investigated the development of metabolic heterogeneity as
structures form during biofilm maturation. Additionally, we investigated how metabolic
regulators control proper development of mature structures and their impact on biofilm
matrix composition. We observed the initiation of metabolic heterogeneity before nutrient
gradients could form within structures, consistent with recent findings that heterogeneity
is a trait that begins from the first stages of biofilm development, when cells encounter a
surface. Furthermore, we observed inactivation of CodY and CcpA have a substantial
impact on central carbon and nitrogen metabolism as well as toxin production and
biofilm development.
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1 Literature Review
1.1 Biofilm development is an intricate process marked by
heterogenic gene expression, matrix production, and other
behaviors.
Biofilms have long been observed, with the earliest documentation in 1933 by Arthur
Henrici, who characterized biofilm growth on submerged surfaces (1). During the 1980s,
a greater appreciation for biofilms was realized when bacterial life in streams was found
to be predominantly in the form of biofilms (2). Not long after, it was postulated that
biofilms develop in a regulated developmental process (3). Indeed, much evidence has
been found to support the notion that microbes follow a largely conserved developmental
process that progresses in multiple stages, though there is still much to be learned.
In contrast to their planktonic counterparts, biofilms are surface attached, structured
communities that are encased in an extracellular matrix (ECM) comprised of a
combination of exopolysaccharides, proteins, and nucleic acids (4). Bacteria may form
biofilms as a way to survive stressors in rapidly changing environmental conditions. The
first known fossils of ancient microorganisms were found in what were sub-marine
hydrothermal vents from at least 3,770 million years ago (5). In fact, the evolution of
Earth’s earliest life-forms has been proposed to occur near these hydrothermal vents,
where reduced hydrothermal fluids mix with seawater to provide an energy-rich
environment and substrates required for metabolic reactions (6). To this day, these
hydrothermal vents support abundant microbial life, whereas the rest of the deep-sea
floor is desolate (7). At these hydrothermal vents, microorganisms utilize the sulfur cycle
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for energy, using ferric and sulfuric minerals from the vents for oxidation reactions (810).
Since nearly all microbial life is found in the biofilm form in nature and the first known
microorganisms were found in microbial mats, perhaps biofilm-forming microbes were
selected for on primordial planet Earth. Biofilm formation would allow microorganisms to
adhere to a surface and persist near a nutrient source, providing an advantage in rapidly
changing environments (5, 11-13). Given the challenging and inhospitable origins of
biofilms, it is not surprising that “modern” biofilms are resistant to starvation, immune
defenses, and antimicrobial agents (14-18).
In addition to resistance to stressful conditions, the hydrothermal vents of our
primordial Earth likely helped drive biofilm evolution in another way: toward the
heterogeneity and division of labor that are essential for maximizing fitness of the
species. Bacteria grown in their natural biofilm form display marked heterogeneity, from
task allocation and specialized matrix-producers to subpopulations of antibiotic-tolerant
cells (19, 20). Historically, studies of bacteria were conducted only in the context of
planktonic cultures measuring averages within the population, completely overlooking
the primary mode of bacterial growth (biofilm) and overlooking differences among the
individuals in the population. In other words, we were trying to make sense of these
complex organisms by averaging the characteristics of cells growing in planktonic
culture, rather than examining the interactions and diversity of individuals living within a
community. Imagine trying to understand organ systems by studying cultured cells. We
would likely learn a great deal about the growth characteristics of these cells, but
completely miss the intricate details of the communal behavior that is essential to their
ultimate function, and to the survival of the whole organism. Yet despite taking cells out
of their natural form of growth, planktonic cells still exhibit marked heterogeneity
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suggesting the processes eliciting heterogenic behavior are deeply engrained in the
functionality of the cell (21).
Understanding the developmental processes driving biofilm formation will aid in the
discovery of new anti-biofilm therapeutics. In the following section, I will discuss the
current understanding of the S. aureus biofilm developmental process.
1.1.1

Stages of biofilm development

Once thought of as merely a collection of cells, more or less randomly organized
within a matrix, biofilm development is now known to be an intricate process culminating
in the formation of complex multicellular structures with common features shared among
most microorganisms, such as differential gene expression, physiological heterogeneity,
and division of labor. The complexity of these structures manifest in multiple ways,
including the formation of fruiting bodies, microcolonies, and floating aggregates,
depending on the environment and characteristics of the organism. For example, motile
bacteria like Bacillus subtilis and Myxococcus xanthus form stalk-like structures called
fruiting bodies, which can become hot spots for spore formation (22, 23). Other bacteria
simply form mounds or “towers” that are often referred to as “microcolonies” (24).
S. aureus biofilms develop in 5 stages: attachment, multiplication, exodus,
maturation, and dispersal (25), as depicted in Figure 3 and outlined below.
Attachment. The first step of the developmental process is to attach to a surface,
which can provide several benefits to an organism. First, all surfaces adsorb proteins
and polysaccharides through molecular interactions, forming a conditioning film upon
which bacteria can adhere and consume nutrients (26-30). The conditioning film has
been shown to change the properties of surfaces, such as the hydrophobicity and
surface charge (31, 32). These changes affect the ability of bacteria to adhere to the
surface, with different bacteria attaching better to different materials and conditioning
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Figure 3. Heterogeneous niches arise during S. aureus biofilm
development. S. aureus biofilm development occurs in five stages: attachment,
multiplication, exodus, maturation, and dispersal. Various adhesins and CWA
proteins are used to adhere to the surface during the attachment stage, followed by
a multiplication stage where matrix components are produced and cell numbers
multiply. The major matrix components are extracellular DNA and cytoplasmic
proteins released from cells. Following multiplication, expression of a nuclease
causes degradation of matrix eDNA, allowing a subset of the population to leave the
community. This allows for the development of heterogeneous microcolonies with
distinct gene expression patterns and matrix composition. Finally, quorum sensing
induces expression of dispersal mechanisms that cause another subset of the
population to leave the community. The dispersed cells presumably go on to form
biofilms at distal sites and the cycle repeats.
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films (33, 34). Importantly, this surface film can be a source of proteins and/or
polysaccharides while also driving away competing organisms that may not favor the
physicochemical properties of a surface/condition film.
Second, attached bacteria can remain in a favorable environment, such as near
hydrothermal vents, rather than drifting away to a less suitable environment (6). As
mentioned above, this may be why biofilm formation is conserved among ancient
bacterial and archaeal species (35, 36), as natural selection may have favored
communally driven bacteria (37).
Finally, compared to planktonic bacteria, adherent bacteria can better withstand
nutrient deprivation, pH changes, immune defenses, and antimicrobial agents (4, 15-18).
Adherence to a surface allows the bacteria to resist these stressors, through a variety of
mechanisms. In one model, the matrix serves as a diffusion barrier to limit the
penetration of molecules into the inner section of the biofilm, thus protecting the interior
cells from antimicrobial agents and immune defenses (38). In another model, a
subpopulation of biofilm-associated cells broadly resistant to stress (persisters) are
already present prior to exposure to stress (the so-called, “bet-hedging” strategy) (39).
Thus, the presence of an external stress (such as an antibiotic) results in the elimination
of a large portion of the population leaving behind the persister cells, which can go on to
form a new biofilm. Although other models of stress resistance exist, it is clear that the
ability of bacterial cells to adhere to a surface and form a biofilm are likely to be essential
for the initiation of one or more of these processes.
Adhesion requires a net attraction between the surface/conditioning film and the
bacterium. Together, the van der Waals, electrostatic, and hydrophobic interactions must
favor interaction for bacteria to adhere to a surface (40). Motile bacteria, like E. coli and
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P. aeruginosa, have flagella that are used to stay near the surface as molecular
interactions form with the surface (41, 42). As a non-motile bacterium, S. aureus (and
other Gram-positive cocci) utilizes an array of proteinaceous and non-proteinaceous
adhesins to strongly adhere to biotic and abiotic surfaces (43). The proteinaceous
adhesins can be grouped into cell wall-anchored (CWA) proteins and non-covalently
linked surface-associated proteins, whereas the non-proteinaceous adhesins consist of
polysaccharide intracellular adhesin (PIA), wall teichoic acids (WTA), or lipoteichoic acid
(LTA). Of the CWA proteins, the microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs) are the most prevalent, and consist of biofilmassociated protein (Bap) (44), clumping factor B (ClfB) (45), fibronection-binding protein
A (FnBPA) and FnBPB (46, 47), S. aureus surface protein C (SasC) and SasG (48-50),
protein A (51), and serine-aspartate repeat protein SdrC (52). These proteins contain an
LPXTG motif that is recognized by sortase, which translocates these proteins across the
membrane and covalently links them to peptidoglycan (53). These proteins contain
ligand-binding domains for interaction with components of the host ECM, such as
fibrinogen, fibronectin, and collagen (54-57). Non-covalently linked proteins involved in
surface interactions are autolysin (Atl) (58-60) and secretable expanded repertoire
adhesive molecules (SERAM) proteins (61). Utilizing this array of adhesins, S. aureus is
quite successful at forming biofilms on a number of surfaces, including skin, heart
valves, and catheters.
Multiplication. After attachment, biofilm cells start to proliferate and produce an
ECM that is composed of polysaccharides, extracellular DNA (eDNA), and/or proteins
(62, 63). The exact composition of the ECM depends on both the organism forming the
biofilm and the specific signals present in the environment. In addition to its role as a
structural scaffold, the ECM can retain nutrients through electrostatic interactions with
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anionic fermentation products (such as formate, lactate, or acetate) and positively
charged matrix components (64-66).
Like S. epidermidis, S. aureus can also produce PIA (67), but is relatively rare.
However, when produced, PIA has been shown to interact with eDNA to form a scaffold
for the biofilm community (68). In addition to PIA and eDNA, S. aureus incorporates a
wide variety of proteins into the ECM (69). Like P. aeruginosa, many cytoplasmic
proteins and virulence factors have been shown to be associated with the biofilm matrix
(69). Foulston et al. and Graf et al. identified “moonlighting” cytoplasmic proteins and
virulence factors that serve as electrostatic bridges between the anionic cell surface,
eDNA, and metabolites (64, 65). Finally, in addition to self-produced matrix components,
S. aureus can incorporate host matrix components, such as heparin and hyaluronic acid,
into its ECM (70, 71). However, among these matrix components, eDNA is a critical
component during the multiplication stage for reasons discussed in the next stage –
exodus.
Exodus. Despite being non-motile, S. aureus biofilm formation has been observed to
follow the same basic maturation and dispersal stages of development as other bacteria
(72, 73). However, the characterization of S. aureus biofilm development with time-lapse
microscopy provided important detail about the developmental process beyond what had
been previously observed (25, 74). This study revealed an additional stage termed,
“exodus”, that followed the initial multiplication stage (Figure 3). Exodus was shown to
be induced by the expression of a secreted nuclease, which resulted in the degradation
of eDNA within the biofilm matrix, allowing a subset of the cells to leave the biofilm (25).
It was speculated that the exodus of these cells allows for the formation of microcolonies
or “towers” during the maturation stage. Deletion of nuc, the gene encoding the secreted
nuclease, resulted in the absence of the exodus stage, causing an uncontrolled
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accumulation of cells and the lack of microcolony development. Importantly, the addition
of exogenous DNase restored exodus and microcolony formation, indicating eDNA
degradation is a crucial step for proper biofilm structuring during the maturation stage
(25).
Maturation. The maturation stage is characterized by the emergence of ‘towers’ or
microcolonies. During this stage, these towers display an increased growth rate,
differential gene expression, and nutrient gradients as a result of the increased biomass
(25, 66, 74). Heterogeneity among niches of the biofilm become evident, from matrix
composition to gene expression (74). What functions these niches perform for the biofilm
population is yet unclear.
Dispersal. Following maturation, degradation of the matrix or upregulation of motility
allows a subset of the biofilm cells to be released and initiate biofilm development at
another location. Various environmental cues can trigger dispersion, such as changes in
oxygen or nutrient availability (75-80). For many organisms, including P. aeruginosa and
E. coli, c-di-GMP is an important signaling molecule for dispersal and plays a major role
in biofilm development (81). Environmental cues can trigger phosphodiesterases (PDEs)
to hydrolyze c-di-GMP and decrease intracellular levels of the signaling molecule,
causing upregulation of motility genes and repression of matrix-producing genes (82,
83). For example, P. aeruginosa has an oxygen-sensitive PDE, RbdA, that hydrolyzes cdi-GMP in response to low oxygen stress (76). The decrease in intracellular c-di-GMP
leads to the production of rhamnolipids (a dispersant) and repression of
exopolysaccharide production (76). Consistent with this finding is the observation that
cells in hypoxic regions of P. aeruginosa biofilm structures revert to the planktonic state
and disperse from the biofilm, leaving a hollowed central void (80, 84), suggesting the
importance of oxygen availability for maintaining biofilm structure.
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In contrast to environmental cues, dispersion can be induced by self-synthesized
signaling molecules (85). For example, S. aureus possesses the Agr quorum sensing
system that detects accumulation of a self-produced auto-inducing peptide (AIP), which
can accumulate within mature biofilm structures (86). After maturation, the Agr system is
activated and upregulates production of proteases and a class of peptides called phenolsoluble modulins (PSMs) that have surfactant-like properties to disrupt the matrix (73,
87). Similarly, nucleases are upregulated after maturation of structures and work to
degrade matrix eDNA and help to cause cell dispersal (88).
1.1.2

Heterogeneity is an intrinsic property of bacterial communities

In recent years, heterogeneity and differential gene expression have become
hallmarks of the biofilm lifestyle (66). In many ways, this was a paradigm shift given the
decades of research on planktonic culture and the prevailing thought that bacterial
cultures are homogeneous. These studies spawned a new way of thinking about
bacterial growth and even about bacteria as complex developmental organisms. So,
where does heterogeneity start? In planktonic culture prior to adherence? Upon
adhesion to the surface? Or when nutrient gradients are established in the threedimensional structure of the biofilm?
Even in planktonic culture, a clonal population can show differential gene expression
patterns, whereby a subpopulation adopts a gene expression profile distinct from the
rest of the population. As described by Dubnau and Losick, this heterogeneity is often
controlled by what has been commonly referred to as a “bistable switch” (89). The
expression of genes under the control of bistable switches can be in two alternative
states, on or off, with no intermediate state. Furthermore, this bifurcation or “bistability”
arises stochastically, without the influence of the environment. Bistable switches require
two conditions: positive autoregulation and non-linearity. The master regulator controlling
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the switch must activate its own promoter, either directly or indirectly, and require a
certain threshold concentration of itself before the auto-stimulatory loop is activated (89).
There is a certain amount of “noise” from the promoter of the master regulator, where
there is a varying amount of expression at any given time in any given cell, stochastically
giving rise to individual cells that surpass the threshold level and activates the autostimulatory loop (90). Bistability allows cells to “hedge bets” to be prepared for
unanticipated fluctuations within the environment, such as nutrient depletion or
antimicrobial exposure, by differentiating into two physiologically distinct populations.
The following examples represent the documented processes known to be (or are
suspected to be) under the control of a bistable switch.
Natural competence. Under the appropriate conditions, approximately 10% of a
population of B. subtilis will undergo a series of regulatory events that leads to a state of
“natural competence”, in which these cells produce DNA transport and recombination
proteins, allowing these competent cells to import naked DNA present in the
environment and incorporate it into their genomes (91, 92). In this system, ComK is the
master regulator governing genetic competence. ComK auto-stimulates its own promoter
in a positive feedback loop (92-94). In addition to itself, the PcomK promoter is affected by
five other transcription factors (Rok, AbrB, CodY, DegU, and Spo0A), a protein that
affects the stability of comK mRNA (Kre), and a quorum-sensing system (MecA and
ComS) (95-105). Clearly, the cell has placed numerous safeguards to tightly modulate
competency, since the physiology of the cell is greatly affected by blocking growth, cell
division, and DNA replication (106, 107). A theoretical analysis by Kussell and Leibler
suggests bistability is the optimal strategy for coping with infrequent changes in the
environment because a subpopulation is already adapted to the new environment, thus
ensuring survival of the clonal population (108). In the case of B. subtilis competence,
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diverting 10% of the population towards natural competence strikes a balance between
optimal growth for most of the population while maintaining a reserve of cells adapted to
respond to potential challenges.
Virulence factor expression. Another example of bistability is the SaePQRS
multicomponent regulatory system in S. aureus, which regulates the expression of
various virulence factors, including the staphylococcal thermonuclease encoded by nuc.
Prior to the exodus stage of S. aureus biofilm development, a stochastic bifurcation
results in the formation of two cell populations that differentially express nuc, a target of
the SaePQRS regulatory system that degrades eDNA within the matrix of the biofilm and
induces the exodus stage (25). In a study by DelMain et al., other targets of the
SaePQRS system (coa and selX) were shown to be under stochastic control (109).
Furthermore, strains with constitutively activated SaeS abrogated stochastic expression,
demonstrating expression of SaePQRS targets in all cells, suggesting this regulator may
function as a bistable switch. Although the SaePQRS-mediated bistable control of gene
expression was first observed during biofilm development, bistable expression is not
limited to biofilm conditions. DelMain et al. showed that the expression of nuc is also
stochastic in planktonic conditions and was likewise dependent on SaeS, mirroring the
gene expression observations of S. aureus biofilms (109).
Surface contact. Upon contact with a surface, P. aeruginosa and E. coli utilize c-diGMP-mediated signal transduction pathways to communicate a transition to sessility
(110, 111). A recent study by Armbruster et al. showed that the c-di-GMP signal
transduction upon P. aeruginosa contact with the surface is not uniform, and marked
heterogeneity arises among the population (112). They discovered that the Wsp
regulatory system, which localizes laterally along the cell and senses contact with
surfaces, generates two physiologically distinct subpopulations through heterogeneous
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c-di-GMP signaling. One subpopulation has high amounts of c-di-GMP and produces
polysaccharides required for biofilm formation, whereas the other subpopulation has low
amounts of c-di-GMP and explores the surface through Type IV pili ((112), Figure 4).
Both subpopulations are required for efficient biofilm formation, representing a good
example of division of labor during early biofilm formation.
Matrix production. Another recent study in E. coli revealed that local matrix
heterogeneity in macrocolony biofilm formation is controlled by a c-di-GMP-dependent
bistable switch. However, in this case, the c-di-GMP-mediated heterogeneity is
controlled by several nested positive and negative feedback loops (113). In this switch,
c-di-GMP levels are intricately controlled by several phosphodiesterases (PdeR and
PdeH) and diguanylate cycles (DgcM and DgcE). PdeR and DgcM interact with each
other and the MlrA transcription factor, the intermediate level regulator of the
σS/MlrA/CsgD transcription factor cascade that controls curli fiber and cellulose
synthesis (114-119). PdeH and DgcE are antagonistically acting enzymes that control cdi-GMP input into the PdhR/DgcM module, particularly as cells approach stationary
phase (115, 116, 119). pdeH is upregulated by σS, a transcriptional regulator active
during stationary phase, whereas dgcE is upregulated by σFliA, a transcriptional regulator
that modulates expression of genes involved in motility and flagellar biosynthesis (115,
120). When c-di-GMP from the PdeH/DgcE module is present, like during the transition
to stationary phase, PdhR dissociates from a direct interaction with DgcM to degrade the
c-di-GMP generated from the PdeH/DgcE module. Then, since PdhR is no longer
associated, the diguanylate cyclase activity of DgcM is activated. Furthermore, DgcM
can interact with MlrA and activate expression of csgD, the transcriptional regulator
responsible for activation of curli fiber and cellulose production (116).
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Figure 4 Contact with the surface generates a heterogeneous response
that leads to biofilm formation. When P. aeruginosa comes into contact with a
surface, a laterally localized Wsp regulatory system senses the contact and
generates two distinct populations: one with high amounts of c-di-GMP and one with
low amounts of c-di-GMP. The population with low c-di-GMP continues to explore
the surface whereas the population with high c-di-GMP downregulates motility and
upregulates production of matrix components. Following the development of
microcolonies, gradients of nutrients and oxygen are established, and cells respond
to their own microenvironment accordingly. For example, hypoxia-induced genes are
upregulated within the center of the microcolony.
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In the “intermediate macrocolony zone”, where matrix-free and matrix-producing cells
are adjacent to each other, Serra and Hengge found that the PdeR/DgcM switch
modulates the local matrix heterogeneity found within this zone (113). Furthermore, the
heterogeneity is not a biofilm-specific behavior, as planktonic cells also differentiated into
matrix-producing and matrix-free subpopulations upon entry into stationary phase, when
cells begin to express csgD.
In subsequent studies, the long-range vertical asymmetry of the matrix architecture
within macrocolony biofilms was found to be due to differential expression of PdeH and
DgcE (115, 116, 119). In wild-type biofilms, the upper layer features a homogeneous
“dense brickwork” matrix composed of cellulose and curli fibers (118, 121, 122). A
double-knockout of pdeH and dgcE abrogated the “dense brickwork” matrix and the
upper layer resembled the architecture found in the heterogeneous horizontal network in
the lower part of the intermediate macrocolony zone (113). Thus, the vertically
asymmetrical matrix architecture that is characteristic of E. coli macrocolony biofilms
was eliminated, showing the importance of PdeH/DgcE input into the PdeR/DgcM
switch. Interestingly, pdeH expression in macrocolonies follows a vertical nutrient
gradient, with high expression in the bottom layer and decreasingly lower expression
further up the macrocolony structure (118), indicating nutrient gradients play a role in the
structuring and heterogeneity of E. coli macrocolony matrix production.
A recent study of B. subtilis biofilms found a division of labor in the production of the
two biofilm matrix components, TasA and EPS (19). Using a fluorescent gene reporter
approach, the differentiation of the cells into three phenotypic populations was observed:
EPS producers, non-producers, and “generalists” that produced both TasA and EPS. As
is a common feature among biofilms, these differentiated subpopulations were stratified
into spatially distinct niches within the biofilm (19, 74). Specialization allows for the
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population to minimize the metabolic costs to produce biofilm matrix molecules, thus,
supporting optimal biofilm expansion and growth (19), a common theme among the
examples of biofilm heterogeneity given in this chapter.
Though the ECM is often thought to be a passive structural scaffold that holds
together biofilm bacteria, it also exerts profound effects on the biofilm cells. For instance,
the TasA amyloid protein produced by B. subtilis can be toxic to vegetative cells (123).
However, due to the heterogeneous distribution of TasA, only vegetative cells near
TasA-producers are affected. The ECM also affects gene expression, as seen by
multiple examples of bacteria sensing an ECM component and transducing that signal
into a response that furthers the development of the biofilm. For example, P. aeruginosa
biofilm cells detect the presence of Psl and uses it as a signal to promote additional
ECM production, helping build the matrix during the early stages of biofilm development
(124). In another example of a positive feedback loop that increases ECM production,
the epsA-O operon in B. subtilis not only encodes enzymes involved in the production of
EPS, but also an EPS-sensing membrane protein coupled with a tyrosine kinase. In the
presence of EPS, these proteins transduce a signal to increase expression of the epsAO operon in a positive feedback loop (125). In S. aureus, DNA-binding proteins form an
electrostatic net with eDNA. A recent study showed that overexpression of one of these
proteins, a lipoprotein named SaeP, increased biofilm formation capacity and expression
of nuc. Since this lipoprotein is an auxiliary component of the SaeRS two-component
system (TCS), SaeP may have a regulatory role in addition to its role in the electrostatic
net of the ECM (126).
Metabolism. In patients with dental caries, polymicrobial communities on the tooth
surface are precisely arranged in a corona-like architecture mediated by an extracellular
scaffold produced by Streptococcus mutans that positions other oral microbes and
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creates localized regions of acidic pH (127). In P. aeruginosa, the three-dimensional
architecture of biofilms has been shown to foster the development of chemical and
nutrient gradients, where nutrients are readily available for peripheral cells but limited for
the inner cells of the biofilm (66, 128). These chemical and nutrient gradients establish
microenvironments that follow the gradient pattern. Using laser capture microscopy,
Williamson et al. isolated fractions of P. aeruginosa biofilms and found gradients of
mRNA abundance, growth rates, and antibiotic tolerance (129). As expected, cells on
the periphery of the P. aeruginosa biofilms were metabolically active, had higher mRNA
levels, and were actively dividing. However, the cells at the bottom of the biofilm grew
slower, had little expression of housekeeping metabolic genes, and were more tolerant
to antibiotics that target actively dividing cells (129). When gradients of nutrients and
oxygen are established within mature biofilm structures, the cells utilize a variety of
sensory strategies to alter gene expression. For example, E. coli utilizes approximately
30 TCSs to respond to environmental signals such as pH, osmolarity, and oxygen (130).
The signals transduced from the environment impact metabolism, virulence factor
production, and gene expression (118, 131-133).
In S. aureus biofilms, genes induced by hypoxic conditions, ldh1 and cidABC, were
upregulated within the center of large towers of S. aureus biofilms, indicating there is an
oxygen gradient in S. aureus biofilm microcolonies like the oxygen gradients seen in P.
aeruginosa biofilms (74, 134, 135). Similarly, hypoxic cytochromes are more highly
expressed in the internal regions of mature E. coli biofilms as a result of the more limited
oxygen levels within these regions of the biofilm (132).
Although the varied extracellular signals within a biofilm clearly have local impacts on
cellular physiology and gene expression in S. aureus, other aspects of the differential
expression of the cidABC and lrgAB operons, both involved in bacterial programmed cell
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death (PCD), cannot be attributed to differences in microenvironment alone. For
example, there are three distinct niches we can identify in S. aureus biofilms grown in
microfluidic flow conditions: fast-growing large microcolonies that express lrgAB and
cidABC, slower-growing small microcolonies that express cidABC only, and a basal layer
that coats the surface and expresses neither cidABC and lrgAB. Both operons are
controlled by regulators, CidR and LytSR, that are responsive to different metabolic cues
(136-139), suggesting that these microcolony types represent different metabolic states.
Furthermore, the two different microcolony types also exhibit differential staining for
eDNA, with the large microcolonies containing eDNA within their matrices, whereas the
small microcolonies do not. Since differential cidABC and lrgAB expression occurs prior
to the formation of mature biofilm structures, these observations suggest that metabolic
heterogeneity arises before the microcolonies form, possibly representing another form
of bistability (74).
Persister formation. Biofilms are notoriously tolerant to antibiotic treatment, of
which persistence plays a key role. Persistence occurs when a subpopulation of cells is
tolerant to antibiotics, either through mutation or slow growth. It is most easily observed
after the treatment of cells with antibiotic and the generation of a bimodal time-kill curve
where the majority of the population is killed but a subpopulation remains (140). These
persister cells, or persisters, can withstand the killing effects of antibiotics but can not
grow in their presence (141, 142). Once antibiotic pressure is relieved, persisters can
resume normal growth and are still susceptible to antibiotics (142, 143). To survive the
antibiotic pressure without a resistance mechanism to break down, export, or modify the
antibiotic or its target (144), persisters adopt a dormant state that down regulates cellular
processes targeted by antibiotics (145-147). All bacterial populations are thought to
contain a small subpopulation of persisters (148, 149) and the frequency of persister cell
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formation is highest in stationary phase culture and during the biofilm mode of growth
(39, 146, 150).
One major mechanism to enter and maintain the dormant state is through paired
toxin-antitoxin (TA) systems (39, 151-154). TA systems are typically comprised of a
stable protein toxin, which can shut down cellular processes, and an unstable antitoxin
that inhibits the toxin and is typically an mRNA or protein (155, 156). The most famous
example of a TA pair is HipAB, the first to be identified and tied to persister cell formation
(157-159). In this system, HipA is a toxin that blocks translation by phosphorylating
glutamyl-tRNA-synthetase, leading to a buildup of uncharged tRNAGlu and synthesis of
the stress response molecule ppGpp (160-162). HipB is the antitoxin of the pair and
directly interacts with HipA, causing a conformational change that inhibits the activity of
HipA (158, 163, 164). A gain-of-function mutation in hipA, named hipA7, enhanced
persistence up to 1,000-fold (157). Analyses of the HipBA promoter complexes showed
that HipA forms homodimers in complexes with HipB and auto-represses its own
expression (165). The hipA7 mutation is located at the HipA-HipA homodimer interface
and caused lower affinity between HipA and HipB, resulting in higher levels of free HipA
that is more stable than the free HipB (165). Thus, several feedback loops that can
explain bistability of the HipAB TA system have been proposed that depend upon HipB
instability, dilution effects from cellular division, and involvement of the stringent
response and proteolytic degradation of HipB (154, 166-170). Overall, the involvement of
ppGpp and the stress response is a common theme among TA systems (171, 172).
Through this stress response system, stress signals such as amino acid depletion or
nutrient limitation (173, 174) disrupt the direct binding of antitoxins to their cognate toxin
pair (171) and cause persistence.
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In addition to environmental factors, bistability and stochastic gene expression play
an important role in the activation of persistence mechanisms (175). For example,
Rotem et al. (176) found that the HipAB TA system is controlled by a bistable switch by
showing there is a threshold concentration of HipA required for persistence and the
duration of persistence depended on how far the threshold was exceeded. In addition to
HipAB, stochastic and non-genetic variability, such as membrane permeability, growth
rates, efflux pumps and porins, cell division events, govern persistence mechanisms
(177-179). As we learn more about mechanisms of persistence, there is continued
appreciation for the different ways persister cells are generated and the potential
bistable switches that control their formation.

1.2 CodY and CcpA regulate central metabolism and help
coordinate biofilm development
S. aureus is adaptable to many environments, as evidenced by the plethora of sites it
can infect in the human body (180). This adaptability can be attributed to the metabolic
versatility available to the organism and its ability to overhaul the regulatory networks
governing metabolism and virulence (181, 182). Two major regulators of staphylococcal
metabolism are CodY and CcpA.
CodY. CodY is a global regulator in Gram positive bacteria, directly or indirectly
regulating over 200 genes, including many metabolic and virulence genes (183). CodY
activity is regulated by levels of branched chain amino acids (BCAAs) and GTP, with
isoleucine predominantly regulating CodY activity (184). Under nutrient rich conditions,
S. aureus scavenges BCAAs from the environment rather than utilize BCAA biosynthetic
pathways (185). As nutrients become depleted from the environment and levels of
BCAAs and GTP decrease, CodY loses affinity for its targets in an order that depends
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on how closely the target gene’s CodY binding site matches the consensus sequence
(183, 186). Oddly enough, genes with similar CodY binding affinity can be grouped by
their function. For example, nutrient transporters are derepressed first, followed by
metabolic synthesis pathways, then virulence factors used to damage tissue and
scavenge resources (186). This stepwise regulation allows S. aureus to adapt to a wide
variety of environments.
Studies have produced mixed results on the effect of CodY inactivation on biofilm
formation, as some studies showed increased biomass in a codY mutant whereas others
showed decreased biomass in a codY mutant (187, 188). Atwood et al. showed this
observation could be due to the strain’s ability to produce PIA, which is correlated with
methicillin resistance (189). codY appears to decrease biomass in methicillin-resistant
strains, which typically have little PIA production. In PIA-producing strains, which are
typically methicillin-susceptible, a codY mutant biofilm appears very “stringy” with
structures tethered together by eDNA and PIA (68). The codY mutant overproduces PIA
in these strain backgrounds because CodY represses the gene operon encoding PIA
biosynthesis pathway, icaADBC. As a result, the mutant overproduces this positively
charged matrix polysaccharide, which in turn acts as a sponge for negatively charged
eDNA.
CcpA. S. aureus undergoes carbon catabolite repression (CCR) to consume
preferred carbon sources before turning on pathways involved in utilizing secondary
carbon sources, such as amino acids. Carbon catabolite protein A (CcpA) is a global
regulator that mediates CCR and carbon catabolite activation (CCA) in S. aureus (190,
191). To achieve this purpose, CcpA works with a phosphotransferase (Hpr), a
bifunctional kinase/phosphatase (HprK), and a sugar phosphotransferase system (PTS)
(191). CcpA controls two regulons, determined by dependency on glucose. However,
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most CcpA-regulated genes are glucose-dependent (192). CcpA can form complexes
with several partners, including HPr and CodY (193). When glucose enters the cells
through PTS, HPr is phosphorylated at a serine residue, after which it can form a
complex with CcpA. The CcpA-HPr-Ser46-P complex has increased affinity for cis-acting
DNA sequences called catabolite responsive element (cre) sites (190), which is further
enhanced by increasing levels of fructose-1,6-bisphosphate (194). CcpA represses
genes within the TCA cycle and secondary carbon source catabolism, such as amino
acids, while activating the glycolytic and fermentative pathways (195). Inactivation of
CcpA results in a loss of biofilm biomass, though ccpA mutants still adhere to surfaces
(196, 197).
Interplay of metabolic regulators and effect on virulence. During an infection, the
host will attempt to sequester nutrients and resources from the invading pathogen. As
nutrients become scarce, S. aureus upregulates expression of virulence factors that aid
acquisition of nutrients from the host, such as toxins that lyse surrounding host cells. As
mentioned above, CcpA and CodY each respond to environmental signals, through
levels of FBP and BCAAs/GTP, respectively, and connect at key nodes of central
metabolism (190, 192, 198). Together, these two regulators sense the nutritional
environment and govern flow of carbon and nitrogen by controlling catabolic and
anabolic pathways involved in sugar and amino acid utilization. As such, it’s no surprise
that these regulators influence the expression of these virulence factor and nutrient
acquisition genes, too. For example, CodY represses the expression of toxins such as
alpha-toxin and nuclease (185). On the other hand, CcpA represses the expression of
alpha-toxin, capsule, and protein A (199). Under nutrient limitation, the expression of
these regulatory targets is derepressed, allowing S. aureus to target and acquire
nutrients from the host.
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2 Materials and Methods
Table 1. List of strains used in this study.
Bacterial

Description

Reference

Strain used to construct recombinant plasmids

(200)

Restriction-deficient strain, highly transformable
UAMS-1 codY::erm

(201)
(202)
(187)

UAMS-1 ccpA::tet

(203)

UAMS-1 codY::erm ccpA::tet

This study

Cloning vector
ackA promoter::sGFP, CmR
pfkA promoter::sGFP, CmR

(109)
This study
This study

pfkA promoter::sGFP, cidABC
promoter::sDsRed, CmR
citZ promoter::sGFP, cidABC promoter::sDsRed,
CmR

This study

Strains
Escherichia
coli
DH5α
S. aureus
RN4220
UAMS-1
UAMS-1
codY::erm
UAMS-1
ccpA::tet
UAMS-1
codY::erm
ccpA::tet
Plasmids
pMRSII
pLB1
pLB18
pLB19
pLB22

This study
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Table 2. Oligonucleotides used in this study
Primer name

Sequence

pLB1-BamHIackA-r
pLB1-SphIackA-f
GFP-KpnI-pfkA-f

5'-GCCGGGATCCATCGTTTGCTTTTTATACTATTTCATTTTCATTTTATC-3'

GFP-EcoRIpfkA-r
GFP-KpnI-citZ-f

5'-CGCGAATTCCTGATTTATCTTTAACTCTAAATTACCAC-3'

GFP-EcoRI-citZr
dsRed-NheIcidABC-f
dsRed-BamHIcidABC-r2
SAV1737-f

5'-CGCGAATTCCCTTTACTGTTTCTTTATGAAATGG-3'

acuC-f

5'- GGTGGACTTGAAATATTCGCTACAG -3'

cna-f

5'- AGTGACATGGTCTAATCTTCCGG -3'

cna-r

5'- TCCACTTTTGATGGCTTATCTGG -3'

RT-rpoD-f

5’- AACTGAATCCAAGTGATCTTAGTGCC -3’

RT-rpoD-r

5’- TCATCACCTTGTTCAATACGTTTGG -3’

RT-alsS-f

5’- GAAGTCACTATATTTGGATGGCACG -3’

RT-alsS-r

5’- CAACTTGCGTATTAGGGCGTAC -3’

RT-pfkA-f

5’- GCAGTTGTTCGTACAGCAATTTACAATG -3’

RT-pfkA-r2

5’- GAATGTACCTCCACGCTGAATCG -3’

RT-glmU-f

5’- CGATAATTTTGGCAGCAGGTAAAGG -3’

RT-glmU-r

5’- GATCGACACCAGAGCCTTTCAC -3’

RT-icaA-f

5’- CTCAATCAAGGCATTAAACAGGCTTC -3’

RT-icaA-r

5’- CCTGTAACTGCACCAAGTTTTGG -3’

RT-citZ-f

5’- CAGATCACGTGCATCCAATGAC -3’

RT-citZ-r

5’- CTCGAGCAAACGCTGTAACTAATG -3’

RT-ackA-f

5’- GTTTCAATTAATCAGAATGCCTGAAGAGG -3’

RT-ackA-r

5’- GCTTCAACATGATCCTTGATATCTTGTACTG -3’

RT-pta-f

5’- CGTATTACCTGAAGGAGAGGACG -3’

RT-pta-r

5’- GCTTTCAATTCACTTGTCGCAGG -3’

RT-ldh1-f

5’- GGTAATGGTGCAGTAGGTTCAATC -3’

RT-ldh1-r

5’- CTGTTGTTGGAGAATATGGTGTGG -3’

RT-accD-f

5’- CCTGCAGGTATTATGACTAAGTGTCC -3’

RT-accD-r

5’- GCTTCTATACGTTTATACGCAGTTAAAGCA -3’

RT-pyc-f

5’- GCTCGTACAACGGCTATCAAG -3’

RT-pyc-r

5’- CATTAGCGGGAAACCAGCTTC -3’

RT-ilvD-f

5’- GCTAAAGAAGCAATTAGAGAAGCCG -3’

RT-ilvD-r

5’- TCACGTGATGGTAGAGAATATCGC -3’

RT-pgi-f

5’- TGGTGCAGGTAGTGACTTCTTAG -3’

5'-CGGCGCATGCCGAAGAAGGACATAGTTATTCACA-3'
5'-GCCGGTACCGCTGAAACAATGAAAATTACTGC-3'

5'-GCCGGTACCCGGTAAAAATGTGTAAAATTCCATG-3'

5'-GCGGCTAGCGGAACGCTTGAATGGACTGGAAAC-3'
5'-GCCGGATCCTAAATACGTCTAAATTGTTACAATAACTATTATAAAGATGGCG-3'
5'- GCAACAAAGGACCATTTAACGATAATAC -3'
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RT-pgi-r

5’- AGAACCACCAATACCGATGACTAC -3’

RT-pdhA-f

5’- AGTTACAAGCCCAATTCGATGC -3’

RT-pdhA-r

5’- TTGTTCATCCGTAAGATCAGGTACTAAG -3’

RT-cidA-f

5’- GCACAAAGTCCAATTAATAATCAAATTATTACTACAAC -3’

RT-cidA-r

5’- GTAAATAAAATAAAAATAGACCAACAATACTGCCG -3’
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2.1 Bacterial strains and culturing
All strains used in this study are listed in Table 1 in the supplemental material.
Staphylococcus aureus strains were cultured in tryptic soy broth (TSB) (Becton
Dickinson formulation without dextrose) supplemented with 0.25% [wt/vol] glucose at
37°C with shaking at 250 rpm, unless otherwise specified. E. coli strains were cultured in
Luria-Bertani (LB) broth. When necessary, antibiotics were added to media during strain
construction and selection [chloramphenicol (10 μg ml-1) (Fisher Scientific),
erythromycin (5 μg ml-1) (TCI America), tetracycline (5 μg ml-1) (Fisher Scientific),
ampicillin (100 μg ml-1) (Sigma)]. Metabolite and RNA-seq analyses were performed
after three hours or six hours of growth, unless otherwise noted.
The UAMS-1-codY ccpA double mutant was generated by bacteriophage Φ11mediated transduction (204) of the ccpA::tetL allele from the JE2 ccpA::tetL strain (205)
into UAMS-1-codY::ermC (187). The replacement of the ccpA gene by the ccpA::tetL
allele was verified by PCR using primers SAV1737-f and acuC-f (203). The UAMS-1
background in all mutants was confirmed by PCR using primers cna-f and cna-r (206).

2.2 Bioflux1000, gene expression analysis, and matrix
degradation treatments
S. aureus biofilm development was assessed using a BioFlux 1000 microfluidic
system (Fluxion Biosciences, Inc., San Francisco, CA), as previously described (74).
Briefly, to grow biofilms in the BioFlux system, the channels in a 48-well plate were first
primed with 210 μl of TSB for one minute at 20.0 dynes/cm2. After priming the channels,
300 μl of fresh 50% TSB supplemented with 0.125% glucose was added to the input
wells and 210 μl of inoculant containing exponentially growing cells diluted to an OD600 of
0.8 was added to the output wells. The channels were seeded by pumping from the
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output wells to the input wells at 2.0 dynes/cm2 for 3 - 6 seconds. After allowing cells to
attach for one hour at 37°C, excess inoculant was aspirated from the output well, and
1.0 ml of 50% TSB supplemented with 0.125% glucose was added to the input well and
pumped at 0.6 dyne/cm2 for 18 h (flow rate, 64 μl/h). After six hours of biofilm formation
in the flow cell, fresh media in the inlet wells were replaced with fresh media alone or
fresh media containing matrix-disrupting enzymes or chemicals with treatments [DNase I
(10 U ml-1), Proteinase K (100 mg ul-1), or sodium metaperiodate (2 mM)]. Bright-field
and fluorescent images were taken every five minutes at 200×magnification. The
settings for gain and exposure were kept constant for all images, of which representative
images are shown for each time point and strain.

2.3 Construction of reporter plasmids
Promoters for pfkA, citZ, and ackA were PCR-amplified using primers listed in Table
2 and PrimeSTAR HS DNA Polymerase (Takara Bio) using the manufacturer's
instructions. For pLB1, the ackA promoter PCR product and pMRSII vector were
digested with BamHI and SphI restriction endonucleases. Then, these fragments were
ligated using Blunt/TA Ligase Master Mix (New England Biolabs) and successful cloning
was confirmed by nucleotide sequencing. Dual reporters were constructed by first
placing the pfkA promoter in front of sgfp in pMRSII, by digesting the pfkA promoter PCR
product and pMRSII vector with KpnI and EcoRI then ligating the fragments using
Blunt/TA Ligase Master Mix (New England Biolabs), making pLB18. Next, pLB18 and
the cidABC promoter PCR product were digested with NheI and BamHI, followed by
ligation to complete the construction of the pLB19 dual pfkA::sgfp cidABC::sDsRed
reporter. Finally, pLB22 was constructed by excising the pfkA promoter from pLB19 by
digesting with KpnI and EcoRI, gel purifying the band containing the vector with
cidABC::sDsRed, then ligated to the KpnI- and EcoRI-digested citZ promoter fragment.
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2.4 Metabolite analyses
2.4.1

Lactate, acetate, glucose, ammonia kits

Samples for metabolite analyses were prepared by centrifuging one ml aliquots of
bacterial cultures for 3 min at 14,000 rpm at 4°C. The supernatants were removed and
stored at −20°C until use. Acetate, glucose, and ammonia concentrations were
determined using kits purchased from R-Biopharm, according to the manufacturer's
protocol.
2.4.2

Acetoin assay

Acetoin concentrations were determined at 560 nm as described previously (207).
Briefly, 140 μl of creatine (0.5% [wt/vol] in water), 200 μl of α-naphthol (5% [wt/vol] in
95% ethanol), and 200 μl KOH (40% [wt/vol] in water) were added in that order to 200 μl
of acetoin standard solution or diluted culture supernatant, with mixing after each
reagent was added. Then, samples were incubated for 15 minutes at room temperature
before mixing again, immediately followed by measurement of absorbance at 560 nm in
the spectrophotometer. The assay was linear over the entire absorbance range of the
spectrophotometer.
2.4.3

HPLC analysis of biofilm effluent

Biofilms were grown in a Bioflux1000 instrument and effluent was collected every 2
hours by extracting excess media from the outlet wells. Since bacteria can reside in the
outlet wells and produce waste, we removed all media from the outlet wells 0.5 h prior to
collection time points. The effluent that accumulated for a half hour was collected,
centrifuged for 3 minutes, and the supernatant was frozen at -20°C until use. Due to
small sample volumes, effluents from 8 wells were pooled together for a single replicate
(of 3 replicates measured) and measured using High-Performance Liquid
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Chromatography as previously described (208). Briefly, a 0.2-μm-pore-size nylon filter
was used to filter the supernatants, which were then put through a Bio-Rad Aminex
HPX-87 column (Bio-Rad) to separate the metabolites. An autosampler injected 5 μl of
sample volume into a thermostatically controlled column (maintained at 65°C), where
analytes were eluted isocratically with 0.005 M H2SO4 at 0.5 ml/min for 30 min.
Chromatograms were integrated using Agilent ChemStation analysis software.

2.5 Metabolomics
Samples were prepared as previously described for metabolomics analysis (209).
Briefly, strains were inoculated in TSB supplemented with 0.25% glucose to an OD600 of
0.05 and grown aerobically at 37°C with shaking at 250 rpm. 10 optical units of bacterial
cultures were harvested and filtered through 0.45 μm membrane (Millipore). Two washes
of five ml cold saline were performed on the membrane-trapped cells, followed by
quenching in ice-cold 60% ethanol containing 2 μM Br-ATP as an internal control. Next,
cells were lysed with a bead homogenizer set to oscillate for three cycles (30 s) of
6,800 rpm with a 10-s pause between each cycle. The tubes were centrifuged at 13,000
rpm and the supernatant was collected, lyophilized, and stored at −80°C.

2.6 mRNA quantification using RT-PCR
RNA was isolated from S. aureus cultures after 3 h and 6 h of growth in TSB
supplemented with 0.25% glucose as described previously (210). Gene-specific primers
(rpoD, pfkA, citZ, icaA, pta, ackA, pdhA, pgi, alsS, cidA, glmU, ldh1, pyc, ilvD, and accD)
were used to perform quantitative real-time PCR (Table S1). Briefly, 1 μg of total RNA
was used to synthesize cDNA using the QuantiNova Reverse Transcription Kit (Qiagen).
cDNA products were amplified from a 1:10 dilution of the samples using the LightCycler
FastStart DNA Master SYBR green I kit (Roche Applied Science) following the
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manufacturer’s protocol. Results reflect 3 biological replicates of each sample measured
in duplicate. The comparative threshold cycle (CT) method (211) was used to calculate
the relative transcript levels with normalization to rpoD transcripts.

2.7 RNA-seq
S. aureus mRNA was sequenced using a NextSeq 550 System with Mid-Output to
acquire 150 single base pair reads. Assembly and analysis were performed using CLC
Genomics software.

2.8 PIA immunoblot
PIA accumulation was determined as previously described (210). Briefly, TSB
medium containing 0.25% glucose was inoculated with equal numbers of bacteria from
overnight cultures. The cultures were grown for 3 h at 37°C with a flask-to-medium ratio
of 10:1 and aerated at 250 rpm. Equal numbers of bacteria were harvested by
centrifugation (2.0 OD600 units), and the PIA was extracted in 0.5 M EDTA by boiling for
10 min and freezing overnight. Samples were incubated with proteinase K for 1 h at
37°C, followed by boiling for 5 min to inactivate proteinase K. Aliquots of PIA were
applied to a neutral nylon membrane (GVS North America) and blocked with 5% skim
milk for 6 h. The nylon membrane was incubated overnight with PIA-specific antibodies,
followed by a 4-h incubation with an anti-rabbit immunoglobulin G–peroxidase conjugate.
The presence of PIA was detected using SuperSignal West Pico chemiluminescent
substrate (Pierce).
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3 Metabolic heterogeneity gives rise to diverse
microcolonies with differences in gene expression
and matrix composition
Heterogeneity is a seemingly embedded feature of life (66). It can muddy the waters
of data analysis, as we tend to try to characterize the most common behavior of a
population and make conclusions based on our understanding of that behavior. Our
understanding of how physiological heterogeneity arises in bacteria is limited, as not a
lot of focus has been placed on this phenomenon. In biofilms, many studies have
pointed to chemical and nutrient gradients causing heterogeneous niches to form (66,
129, 212). However, recent studies have shown heterogeneity starts upon contact with a
surface, far sooner than the formation of nutrient gradients (112).
In our laboratory, we have endeavored to characterize biofilm development using a
microfluidic flow cell system called the Bioflux1000. Early into our observations, we
discovered differential gene expression between different niches of the biofilm that
developed after the exodus stage (74). These niches consisted of a basal layer, a small
tower type, and a large tower type. The basal layer did not grow as fast as the cells in
either of the towers, whereas the large tower cells grew the fastest. We characterized
the two tower types based on their expression of two operons (cidABC and lrgAB) and
incorporation of dead cells and eDNA into these towers. The small towers constitutively
expressed cidABC whereas the large tower only expressed cidABC after a substantial
biomass had been achieved. Furthermore, the large tower was the only niche that
expressed lrgAB, which it did constitutively. The expression of cidABC and lrgAB began
for these towers from the onset of their growth, indicating the nutritional environment had
little to do with triggering their development as there is a constant flow of nutrients in this
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system. Does heterogeneity arise stochastically, a response to localized nutrient
gradients, or perhaps both?
In this chapter, we will discuss the heterogenic nature of S. aureus biofilm
development, particularly as it pertains to metabolic shifts within subpopulations of the
biofilm during the maturation stage of development.

3.1 Metabolite analysis reveals existence of multiple biofilm
niches in a constant flow environment
After the exodus stage of S. aureus biofilm development, subpopulations of cells
undergo rapid growth, differential expression of cidABC and lrgAB, with the ultimate
formation of morphologically diverse microcolonies (74). Since the regulators for cidABC
and lrgAB respond to metabolic cues, we hypothesized there is a stochastic change in
the expression of metabolic genes that leads to the development of diverse biofilm
niches.
S. aureus is an organism with a preferred carbon source: glucose (191). When in the
presence of excess oxygen and glucose, S. aureus will rapidly consume glucose,
produce and secrete acetate, and regenerate reducing equivalents through the
respiratory chain (Figure 5A). Once glucose is fully consumed, S. aureus will consume
acetate to fuel the TCA cycle and continue aerobic respiration (213, 214). When oxygen
is limited, as in a hypoxic environment, S. aureus will rapidly consume glucose but
instead of producing acetate it produces lactate, due to a drop in respiratory chain
activity and a need to regenerate NAD+ to support glycolytic activity (Figure 5B) (213,
215). To investigate the establishment of niches during S. aureus biofilm development,
we measured the metabolic byproducts of biofilms grown in a microfluidic flow cell
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Figure 5. Characterization of metabolites produced in aerobic,
microaerobic, and biofilm conditions. (A) In aerobic conditions, glucose is rapidly
consumed and used to produce acetate. After exhaustion of glucose, acetate is used
as a carbon source to support further growth. (B) In microaerobic conditions,
reduced respiratory chain activity requires cells to utilize ldh1 to produce lactate
while regenerating NAD+ to support glycolytic activity. Meanwhile, acetate production
remains active but at a much lower level than in aerobic conditions. (C) Biofilms
grown in a constant flow environment produce acetate, lactate, and pyruvate as
metabolic byproducts, indicating the presence of multiple metabolic niches.
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system by collecting samples every two hours. We observed the formation of multiple
metabolic niches by the very first timepoint measured, as indicated by robust production
of both acetate and lactate (Figure 5C). The production of both of these weak acids,
including higher concentrations of acetate than lactate, indicates there are at least two
subpopulations utilizing different metabolic pathways despite access to the same
nutrient resources. One subpopulation utilizes a fully functional respiratory chain, very
active glycolytic pathway, and robust Pta-AckA activity to rapidly metabolize glucose, as
in aerobic conditions (Figure 3A). Meanwhile, another subpopulation is fermenting to
produce lactate, as in microaerobic conditions (Figure 3B). The formation of these
niches by the first timepoint further supports the notion of heterogeneity initiating before
nutrient gradients can be established, as mature structures have not formed and there is
a constant flow of fresh nutrients over these cells.

3.2 Metabolic gene reporters reveal differences in nutrient
utilization
Population level analysis of metabolite concentrations revealed multiple niches within
the S. aureus biofilm, but it didn’t inform us about where or how these niches formed. To
better understand spatiotemporal development of metabolic niches, we devised a
fluorescent gene reporter approach that allowed us to track when metabolic pathways
were activated, with the idea that expression of a metabolic gene is indicative of a
metabolic pathway being activated. For this approach to work, we needed to look at
genes under heavy transcriptional regulation, since our fluorescent reporters won’t be
responsive to other forms of metabolic regulation, such as allosteric regulation of the
metabolic enzyme. For this reason, we chose pfkA to serve as our glycolytic reporter,
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because it’s promoter contains a putative catabolite responsive element (cre) site (190)
in front of the transcription start site, indicating CcpA is an activator of pfkA expression
(181). For our TCA cycle reporter, we chose the gene encoding the first enzyme of the
pathway, citZ, which is directly repressed by CcpA (216). Choosing a reporter for the
Pta-AckA pathway was difficult, as there is evidence of transcriptional regulation by
CcpA in B. subtilis, but none identified in S. aureus yet (195, 217, 218). Reporters for
both pta and ackA were made, but only the ackA reporter fusion was used in this study,
as it showed upregulated expression when the Pta-AckA pathway was active (see
below).
3.2.1

pfkA, ackA, citZ, and ldh1 reporters were expressed when their respective
pathways were activated

As mentioned above, In the presence of excess glucose and oxygen, S. aureus
preferentially consumes glucose and produces acetate in the presence of excess
glucose and oxygen. Once glucose is exhausted, S. aureus imports the acetate and
converts it to acetyl-CoA, which is then used to fuel the TCA cycle and further growth
(219). Since glycolysis and the Pta-AckA pathways are utilized during the exponential
phase as described above, we expected a sharp increase in signal from our pfkA and
ackA reporters during this time. As shown in Figure 4A, we observed exactly that: our
glycolytic and Pta-AckA pathway reporters were working as expected and strongly
fluoresced during the time frame when glucose is rapidly consumed from the media.
Furthermore, after glucose was depleted, acetate was consumed and used to fuel
the TCA cycle, which had been derepressed as shown by our citZ reporter. These data
validated our approach that transcriptional reporter fusions could be used as a tool for
spatiotemporal analysis of metabolic pathway activation.
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Figure 4. Validation of gene reporter approach using glycolysis, Pta-AckA
pathway, and TCA cycle as model metabolic pathways. (A) Normalized gene
expression from our gene reporter fusions (pfkA, ackA) was compared with media
glucose levels to assess whether our approach reflected the metabolic status of
cells. (B) Following glucose depletion, we assessed whether our citZ reporter
reflected the increased TCA cycle activity during the post-exponential phase of
growth when acetate is consumed to support further growth.
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3.2.2

Expression of pfkA is stronger in large microcolonies

Previous studies have shown glycolytic genes are upregulated in biofilms, more so
than their planktonic counterparts (220, 221). To examine glycolytic gene expression
and ask whether there is differential expression of pfkA during biofilm development, we
constructed a dual reporter fusion where the cidABC promoter drove expression of
dsRed and the pfkA promoter controlled expression of sgfp. We chose to make a dual
reporter so that we could tag the different niches that form during S. aureus biofilm
development, where large towers express cidABC late in development when a
substantial biomass has accumulated and small towers constitutively express cidABC
(74).
As shown in Figure 5, we were fortunate enough to have both tower types develop in
the same field of view, which allowed for a good comparison of glycolytic gene
expression within these niches. Throughout the development of these biofilms, we
observed a low level of constitutive pfkA expression. In the small tower, which is
constitutively expressing cidABC (red), we observed no relative increase in pfkA
expression (green), indicating this niche is not upregulating glycolysis to support its
growth. However, in the large tower, which did not express cidABC until late in its
development, we observed strong upregulation of pfkA, indicating the large tower niche
requires increased expression of glycolytic genes to support its growth.

37

Figure 5. pfkA is constitutively expressed but strongest in large towers as
they develop. A dual pfkA::sgfp, cidABC::sDsRed reporter was used to detect
spatiotemporal changes in glycolytic activity during biofilm development. Large
towers do not express cidABC until later in development, whereas small towers
constitutively express cidABC. In the same field of view, we observed both a large
and small tower develop, allowing a good comparison between these niches for
glycolytic gene expression. Representative images are shown of large and small
towers developing next to each other at 13h, 15h, and 17h.
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3.2.3

Expression of citZ is limited to center of large microcolonies

In our microfluidic flow cell system, nutrients are constantly replenished. As a result,
we did not expect to see much expression of our citZ reporter, since TCA cycle activity
should be repressed (191). However, biofilms do not always follow cues from their
environment due to their fundamental heterogeneous nature (66). Normally induced in
hypoxic conditions, cidABC was nevertheless constitutively expressed in small towers
despite an oxygen-rich environment (74), underscoring the physiological heterogeneity
and diverse microenvironmental niches within biofilms.
Therefore, despite an environment replete with glucose and oxygen, we assessed
TCA cycle activity during biofilm development using our gene reporter approach. As
before, we used a dual reporter containing the promoter for cidABC driving expression of
dsRed. This time, however, we fused the promoter for citZ to sgfp. As shown in Figure 6,
we did not observe much citZ expression throughout biofilm development until the late
stages of large tower formation, when the center of the biomass presumably becomes
hypoxic. We have thought the center of these large towers are hypoxic due to the
biomass presumably limiting oxygen diffusion to this area. Upregulation of cidABC
expression supported this hypothesis (74). Transcriptional regulation of the TCA cycle is
governed mostly by the presence of oxygen and the carbon source (213, 214), where
the presence of glucose and/or the absence of oxygen cause transcriptional repression
of the TCA cycle. Therefore, it is not clear why the TCA cycle is derepressed in the
presumably hypoxic environment in the center of a large tower.
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Figure 6. citZ is expressed in the center of large towers. A dual citZ::sgfp,
cidABC::sDsRed reporter was used to detect spatiotemporal changes in TCA cycle
activity during biofilm development. Small and large towers were observed in
different fields of view, so representative images of small and large towers after 17h
of growth are shown, with small towers in the top panels and large towers in the
bottom panels.
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3.2.4

The Pta-AckA pathway is important for large microcolony development

Finally, we looked at the expression of ackA during biofilm development. The PtaAckA pathway is heavily utilized during S. aureus growth in excess oxygen and glucose
(206), so at least a basal level of constitutive ackA expression was expected. In this
experiment, we tagged tower types using Propidium Iodide (PI), which stains eDNA and
dead cells, because only large towers incorporate eDNA and dead cells into their matrix
(74). We observed a basal level of ackA expression, as expected, but also a strong
upregulation of ackA expression in the large towers (Figure 7), similar to our observation
of pfkA expression during large tower development (Figure 5). However, even stronger
upregulation of ackA expression appeared in the center of the large towers. It’s likely this
niche within the center of mature large towers is microaerobic, as evidenced by ackA
expression and ldh1 expression (unpublished data), providing an example of how the
microenvironment influences metabolic gene expression within biofilms (66).
These data also suggest the Pta-AckA pathway is critical for large tower
development, since the pathway is upregulated during large tower development and the
upregulation gets stronger after enough biomass has accumulated and the center
becomes more hypoxic (Figure 7). In some unpublished work from our lab, inactivation
of either pta or ackA leads to formation of biofilms lacking the lrg-expressing large
towers (unpublished data), supporting the idea that the Pta-AckA pathway is critical for
the development of large towers.
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Figure 7. ackA is strongly expressed in large towers, especially within the
center of the biomass. An ackA::sgfp reporter was used to investigate Pta-AckA
pathway activity during biofilm development. Tower types were tagged with
Propidium Iodide (PI), which stains eDNA and dead cells. Low constitutive ackA
expression in the basal layer gave way to strong upregulated ackA expression in
large towers but not small towers. Representative images after 17h of biofilm growth
are shown.
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3.3 Discussion
In this study, we sought to answer the question of how, where, and why physiological
heterogeneity arises during biofilm development. Though we still do not understand the
answers to this question, our findings revealed key characteristics about physiological
heterogeneity within biofilms.
As Figure 3C shows, there are multiple metabolic niches that arise during biofilm
development. Furthermore, the metabolic heterogeneity among these niches initiates
from the first stages of biofilm development. Notably, this means the cells are within the
same environmental conditions, suggesting heterogeneity is an innate strategy to
physiologically diversify the population.
However, we also observed evidence that physiological heterogeneity arises due to
the influence of the microenvironment. We observed increased ackA and ldh1
expression within the center of mature large towers (Figure 7, unpublished data),
indicating this niche is microaerobic (Figure 3A, 3B).
Regardless of the origin of physiological heterogeneity, it undoubtedly provides an
advantage to the biofilm community. Biofilm bacteria are readily adaptable to extreme
conditions, such as ultraviolet (UV) radiation, high or low temperature, high or low pH,
high salinity, high pressure, and nutrient deprivation (222-226). One explanation for how
biofilms can survive such harsh conditions is physiological heterogeneity, where there is
always a subpopulation already adapted or ready to adapt to survive in a new
environmental condition. For example, B. subtilis maintains approximately 10% of its
population in a competent state, for the purpose of adapting to a new stress if one arises
(91, 92). Furthermore, due to the population being in multiple metabolic states (e.g.
growing, dormant, stress-adapted), biofilm bacteria can withstand pressures such as
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antibiotic treatment (39, 227). This idea has been termed the “insurance hypothesis”,
where diversity protects the community from unstable environmental conditions (228).
While physiological heterogeneity has been characterized in biofilms before, our
study provides some insight into spatial and temporal changes that occur during biofilm
development. We discovered physiological heterogeneity is both an innate process,
where bacteria are hard-wired to differentiate into multiple metabolic states, as well as a
response to microenvironmental cues, such as low oxygen conditions within large biofilm
structures.

4 Interplay between CodY and CcpA in regulating
central metabolism and biofilm formation in S.
aureus.
Staphylococcus aureus is a leading cause of bacteremia, endocarditis, skin and soft
tissue infections, and osteomyelitis (229). Along with the plethora of sites it can infect in
the human body (180), S. aureus is resistant to several antibiotics and was listed in the
High Priority category of the WHO’s global priority pathogen list (230). The adaptability
of S. aureus to diverse environments can be attributed to the metabolic versatility of the
organism and its ability to overhaul the regulatory networks governing metabolism and
virulence (181, 182). It has been shown that S. aureus controls the expression of toxins,
biofilm genes, and metabolic genes through the use of two global transcriptional
regulators, CodY and CcpA, that sense and respond to environmental conditions (186,
192, 195-197, 199).
CodY is a global transcriptional regulator in Gram positive bacteria, directly or
indirectly regulating over 200 genes, including numerous metabolic genes (183). CodY
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activity is regulated by levels of branched chain amino acids (BCAAs) and GTP, tying its
activity to nutrient availability. As nutrients become limited and levels of BCAAs and GTP
decrease, CodY loses affinity for its targets, which are under repression by CodY (231).
Promoters have varying affinities for CodY, typically grouped by their functions. DNA
sequences with a higher affinity for CodY will continue to be repressed in conditions with
slight nutrient limitation, and as conditions become more deplete of nutrients there is a
stepwise derepression of CodY target genes (183). For example, nutrient transporters
are derepressed first, followed by metabolic synthesis pathways, then virulence factors
used to damage tissues and scavenge resources are derepressed (186). This stepwise
regulation allows S. aureus to adapt to a wide variety of environments.
Carbon catabolite protein A (CcpA) is another global transcriptional regulator in
Gram positive bacteria that is responsible for carbon catabolite repression (CCR) and
carbon catabolite activation (190, 191). CcpA regulation can be glucose-dependent or independent, where the majority of the genes undergo glucose-dependent regulation by
CcpA (192). CcpA can form complexes with several partners, including HPr and CodY
(193). When glucose enters the cells through the sugar phosphotransferase system
(PTS), HPr is phosphorylated at a serine residue (Ser46), after which it can form a
complex with CcpA. The CcpA-HPr-Ser46-P complex has increased affinity for catabolite
responsive element (cre) sites (190), which is further enhanced by elevated levels of
glucose-6-phosphate and fructose-1,6-bisphosphate (194). CcpA represses genes within
the TCA cycle and secondary carbon source catabolism, such as amino acids, while
activating genes encoding components of the glycolytic and fermentative pathways
(195).
Like CodY, CcpA activity is regulated by environmental conditions, specifically
through levels of fructose-1,6-bisphosphate (FBP) and glucose-6-phosphate (191).
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Interestingly, the metabolic gene targets of CodY and CcpA meet at key nodes of central
metabolism, such as amino acid biosynthetic pathways, the TCA cycle, and glycolysis
(190, 192, 198). Together, these two regulators sense the nutritional environment and
govern flow of carbon and nitrogen by controlling catabolic and anabolic pathways
involved in sugar and amino acid utilization. Previous studies have implicated the
importance of these metabolic regulators during biofilm formation. It has been shown
that inactivation of ccpA results in a loss of biofilm biomass, though the ccpA mutants
retain the ability to adhere to a surface (196, 197). Inactivation of codY has been found
to either increase or decrease biofilm biomass, depending on the strain of S. aureus
used in the study (187, 188). Atwood et al. attributed this to the strain-specific ability to
produce poly-N-acetylglucosamine (PIA) polysaccharide, which is correlated with
methicillin resistance (189). Inactivation of codY appears to decrease biofilm biomass in
methicillin-resistant strains, which typically produce low amounts of PIA, whereas
methicillin-sensitive strains typically produce PIA and form biofilms with very “stringy”
structures tethered together by eDNA and PIA (68, 189). The operon encoding the
biosynthetic machinery for producing PIA, icaADBC, is under direct repression by CodY.
As a result, the codY mutant overproduces this positively charged matrix polysaccharide,
which in turn acts as a sponge for negatively charged eDNA (68).
In the current study, we investigated the impact of CodY and CcpA inactivation on
central metabolism and biofilm formation in S. aureus. Consistent with previous findings,
we observed disrupted flow through central metabolic pathways, such as glycolysis and
amino acid biosynthesis (185, 192, 195). Furthermore, rather than completely abrogate
PIA production, disruption of carbon flow through inactivation of ccpA in a codY mutant
only reduced PIA production. Despite a reduction in PIA production, the biofilm formed
by a codY ccpA mutant contained the “stringy” structures, like the codY mutant, that are
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held together by PIA and eDNA. However, upon treatment with DNase I, only the
“stringy” structures within the codY mutant biofilms were disrupted whereas the “stringy”
structures of the codY ccpA mutant biofilms remained intact, suggesting much less
eDNA is incorporated into the matrix. Overall, disruption of central metabolism has a
major impact on cellular physiology and proper biofilm development.

4.1 Growth characteristics of codY, ccpA, and codY ccpA
As master regulators in many Gram positive bacteria, CodY and CcpA play major
roles during growth by modulating flow through key metabolic pathways, controlling toxin
production, and coordinating biofilm development (68, 186, 192, 196, 197). Both of these
regulators have been shown to interact with other regulators, including each other, so we
wanted to investigate the interplay between them throughout the growth cycle (193). We
started by growing planktonic cultures of the wild-type (UAMS-1) strain and the codY,
ccpA, and codY ccpA mutant strains and performing hourly measurements of OD600 and
extracellular pH (Fig. 8A). As shown in Fig. 8A, the codY mutant has a slight growth
defect during the exponential phase of growth and the ccpA and codY ccpA mutants
have a more pronounced growth defect that lasts until stationary phase. Furthermore,
the ccpA and codY ccpA mutants fail to acidify the media during the exponential phase,
in contrast to the WT and the codY mutant (Fig. 8A), indicating the ccpA and codY ccpA
mutants do not produce as many weak acids during the exponential phase as the WT or
the codY mutant. Using growth data between zero and three hours of growth, we
calculated the doubling time for each strain (Fig. 8B). Previous studies have found the
doubling time of S. aureus to be between 24-60 minutes, depending on the nutrient
conditions (232). In our study, we found the WT had a doubling time of approximately 30
minutes in TSB supplemented with 0.25% glucose (Fig. 8B). Also, in accordance with
the growth curve, we observed a slightly longer doubling time for the codY mutant, and
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Figure 8. Growth characteristics of wild-type (WT) and the codY, ccpA, and
codY ccpA mutants in TSB supplemented with glucose. (A) Each strain was
cultured in TSB supplemented with 0.25% glucose and incubated for 12 hours at
37°C with shaking (250 rpm). Optical density (OD600) and extracellular pH were
measured hourly. (B) Using the change in OD600 between zero and three hours of
growth (exponential phase), we calculated the number of new generations of
bacteria and the doubling time for each strain.
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even longer doubling times for the ccpA and codY ccpA mutants (Fig. 8B). In conclusion,
inactivation of codY slightly impacts growth in TSB supplemented with 0.25% glucose,
whereas inactivation of ccpA or both codY and ccpA resulted in a more significant
growth impairment.
Next, we collected culture supernatants over the course of 12 hours of growth to
analyze extracellular metabolites. First, we measured glucose concentrations and
observed the ccpA and codY ccpA mutants were much slower to consume glucose, as
expected since CcpA mediates carbon catabolite repression (Fig. 9A, (191)). Similarly,
the ccpA and codY ccpA produced less acetate than the WT during the exponential
phase, which explains the lack of media acidification observed in Fig. 8A (Fig. 9B).
Though the change was much more subtle, the codY mutant showed a slight reduction
in acetate production as well (Fig. 9B). Next, we measured ammonia production, since
ammonia is produced from deamination reactions during amino acid catabolism (233).
As expected, the ccpA and codY ccpA mutants produced more ammonia than the WT
and the codY mutant during the exponential phase of growth, suggesting ccpA
inactivation resulted in increased amino acid consumption due to disruption of carbon
catabolite repression (Fig. 9C). Finally, since acetoin is a neutral molecule produced
during overflow metabolism to prevent intracellular and extracellular acidification, we
measured acetoin production (Fig. 9D). We observed a decrease in acetoin production
in the ccpA mutant, suggesting CcpA is an activator of the alsSD operon encoding the
enzymes required for acetoin production (234) Additionally, we observed a strong
increase of acetoin production in the codY mutant, indicating CodY is a repressor of the
alsSD operon.
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Figure 9. Analysis of extracellular metabolites reveals major changes to
central metabolism as a result of ccpA and/or codY inactivation. (A) The ccpA
and codY ccpA mutants consume glucose slower than the codY mutant and WT. (B)
The codY mutant has a slightly lower yield of acetate produced during the
exponential phase of growth, whereas the ccpA and codY ccpA mutant produce
much less acetate than the WT. (C) The ccpA and codY ccpA mutants produce more
ammonia during the exponential phase of growth, likely due to consumption of more
amino acids compared to the WT. (D) The codY overproduces acetoin whereas the
ccpA mutant appears to have decreased acetoin production.
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4.2 Transcriptomic analysis reveals major changes to central
carbon and nitrogen metabolism in codY and ccpA mutants
To gain a better understanding of the interplay between two master transcriptional
regulators, we performed an RNA-seq analysis on the codY, ccpA, and codY ccpA
mutants and compared them to the WT after three and six hours of growth. As
mentioned earlier, CodY and CcpA regulate many central metabolic genes (185, 195). In
Figure 10A, we show changes to metabolic gene expression after three hours of growth,
when the cultures are in exponential phase and both regulators are active. Colorcoordinated arrows indicate changes in metabolic gene expression for each mutant
compared to the WT (Fig. 10A). Like Majerczyk et al., we observed overexpression of
genes involved in amino acid biosynthesis (ilv-leu operon), peptide and amino acid
transport (yveA, gmpC, gsiD, abgT), toxin production (hlgB, hlgD, lukF, lukH, seu), and
biofilm formation (icaADBC, nuc1, sdrC) in the codY mutant (Fig. 10A) (data not shown)
(185). The codY mutant also showed a downregulation of sucCD expression, in contrast
to the increase in sucAB expression that Majerczyk et al. observed in the codY mutant
(185). It’s not clear what caused this discrepancy, though further experiments in the next
section would indicate codY has decreased expression of TCA cycle genes (Fig. 11A),
suggesting CodY is a direct or indirect activator of the TCA cycle. Furthermore, we
observed a decrease in purine metabolism (pur operon and guaC) and an increase in
purine salvage expression (xpt) in the codY mutant (235) (Fig. 10A). Overall, our
transcriptomic analysis supports the idea that CodY represses biosynthetic pathways in
favor of utilization of nutrients from the environment (186).
As for the ccpA mutant, we observed decreased expression of glycolytic genes (fda,
fba, gpmA) and virulence genes (agrAD, seO), consistent with results from previous
studies on the CcpA regulon (192, 195, 199). Interestingly, our transcriptomic analysis
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Figure 10. RNA seq analysis on metabolic genes reveals an interplay
between CodY and CcpA to regulate metabolism. (A) Changes in metabolic gene
expression compared to WT after three hours of growth are shown, with colorcoordinated arrows indicating changes in the codY (blue), ccpA (red), and codY
ccpA (green) mutants. (B) Changes in metabolic gene expression after six hours of
growth are shown, with color-coordinated arrows depicting the changes in
expression for each mutant compared to WT.
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revealed increased expression of pgl, encoding the first enzyme of the Pentose
Phosphate Pathway (PPP). A previous study showed the gntRKP operon was the only
component of the PPP to be at least partially regulated by CcpA (195). The PPP is
important for maintaining redox balance within the cell and produces components for
nucleotide biosynthesis, suggesting CcpA plays a direct or indirect role in maintaining
redox balance through the PPP (236). Additionally, we observed an increase in acsA
expression, which catalyzes the reaction to make acetyl-CoA from acetate (Fig. 10A). A
previous study by Seidl et al. did not detect significant changes to acsA gene expression
in their transcriptomic analysis, but did observe increased levels of acetyl-CoA
synthetase enzyme in the ccpA mutant (195). De-repression of acsA during exponential
phase indicates ccpA is consuming secondary carbon sources such as acetate, even in
the presence of excess glucose and oxygen. Further evidence of disruption to carbon
catabolite repression is upregulation of peptide and amino acid transporters in the ccpA
mutant, supporting our conclusion that deamination reactions during amino acid
consumption are resulting in increased ammonia production by the ccpA mutant during
exponential phase (data not shown, Fig. 9C).
In independent experiments, Majerczyk et al. and Seidl et al. observed CodY and
CcpA involvement in regulation of purine metabolism (185, 195). We observed
decreased purine biosynthesis in all of the mutants, suggesting purine biosynthesis is a
tightly regulated pathway that is sensitive to changes in central metabolism (Fig. 10A).
Since ATP is used as a substrate for the initial reactions of both pyrimidine and purine
biosynthesis, the decrease in expression of these biosynthetic genes could be due to a
lack of ATP in the mutant strain (237). At the three-hour time point, we indeed observed
a small decrease in intracellular ATP levels for the codY mutant (Fig. 11). Since a purine
salvage gene (xpt) is also upregulated, this would suggest the codY mutant is salvaging

53

Figure 11. Measurement of intracellular pools of ATP reveals
overabundance of ATP in the ccpA and cod codY mutants. Intracellular ATP
concentrations were determined for the WT, codY mutant, ccpA mutant, and codY
ccpA mutant after three and six hours of aerobic growth in TSB containing 0.25%
glucose.
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purines from the environment and displays decrease purine biosynthesis (Fig. 10A, Fig.
11). In the ccpA and codY ccpA mutants, however, there is an increase in ATP levels, in
direct contrast to the hypothesis that ATP is limiting purine biosynthesis in these two
strains (Fig. 11). Rather, since doubling time is increased in the ccpA and codY ccpA
mutants (Fig. 8B), we believe these strains are downregulating purine biosynthesis to
adjust to a slower growth. Furthermore, the TCA cycle is de-repressed and an
abundance of NADH is available within the ccpA and codY ccpA mutants (218), leading
to increased ATP levels despite slower growth, hence the need to downregulate purine
biosynthesis.
The codY ccpA mutant shared characteristics with both single mutants and
phenocopied each mutant in different ways. For example, the codY ccpA mutant
exhibited decreased expression of glycolytic genes (like the ccpA mutant) and increased
amino acid biosynthesis genes (like the codY mutant). As mentioned above, inactivation
of ccpA resulted in decreased expression of the agr system, a master regulatory system
for virulence gene expression in S. aureus (199, 238). Conversely, CodY represses the
expression of agr and as a result there is overexpression of various S. aureus toxins in
the codY mutant, including hlgB, hlgD, lukF, lukH, and seu (183, 185). Therefore, the
codY and ccpA mutations have opposing effects on the expression of the key virulence
factor regulatory gene, agr, resulting in opposing phenotypes for expression of toxin
genes (199, 239). In our analysis, the double codY ccpA mutant did not show increased
expression of toxins, indicating the ccpA phenotype of decreased toxin expression was
dominant over the codY phenotype of overexpression of these toxins (data not shown).
These data indicate direct or indirect activation of the agr locus by CcpA is required for
toxin expression, regardless of CodY repression of agr. Similarly, the derepression of
biofilm formation genes (ica, nuc, or sdrC) caused by inactivation of codY was ablated in
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the codY ccpA mutant, again indicating the effect of ccpA mutation was dominant over
the effect of codY mutation (data not shown).
Altogether, during the exponential phase of growth when nutrients are abundant,
CodY and CcpA reduce carbon flow from secondary carbon sources and shut down
toxin production to optimize growth (Fig. 10A, data not shown). Inactivation of these
metabolic regulators has detrimental effects to exponential phase growth (Fig. 8A,B, Fig.
9A-D).
During the post-exponential phase of growth, when the WT has depleted glucose
and is utilizing acetate to fuel the TCA cycle to support further growth, we observed
some interesting differences in the codY, ccpA, and codY ccpA mutants. Due to slower
growth and glucose consumption (Fig. 8A,B, Fig. 9A), the ccpA and codY ccpA mutants
still have glucose available to them at this time-point (six hours). As a result, we
observed several differences between the WT, the ccpA mutant, and the codY ccpA
mutant. First, we observed increased expression of the PTS glucose transporter glcB in
both the ccpA and codY ccpA mutants (Fig. 10B). However, we only observed increased
expression of glycolytic genes (fda, gapA1) in the ccpA mutant, indicating CodY may be
required for activation of glycolytic gene expression during the post-exponential phase.
Additionally, we observed decreased expression of the gluconeogenic gene gapA2 in
the ccpA and codY ccpA mutants, which is logical since glucose is still available to them
whereas glucose is exhausted from the media for the WT (Fig. 9A, Fig. 10B).
Furthermore, pathways for carbon overflow (pfl) were overexpressed in the ccpA and
codY ccpA mutants, indicating increased flux from the central carbon metabolite
pyruvate compared to the WT. Finally, the ccpA mutant showed increased ackA
expression, which encodes the second enzyme of the Pta-AckA pathway, which is
critical for production of acetate during growth in excess glucose and oxygen (206).
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These observations can be attributed to differences in glucose availability between the
WT and the ccpA and codY ccpA mutants.
The main differences between the WT and the codY mutant in the post-exponential
phase was the increased expression of amino acid biosynthesis genes (ilv-leu operon)
and proteases (aur, sspB, sspC) and the decreased expression of pfl (formate
production) and the pur operon (purine biosynthesis) in the codY mutant (Fig. 10B, data
not shown). These data indicate amino acids are still available to the WT and CodY
plays a role repressing exoprotease expression (that would scavenge nutrients from the
host) as well as amino acid biosynthesis during the post-exponential phase of growth
(Fig. 10B, data not shown).

4.3 Targeted gene expression analysis reveals CodY and CcpA
coordinate metabolism and virulence
To validate the RNA-seq findings and to get a closer look at gene expression at key
metabolic nodes, we performed RT-PCR on select gene targets (pgi, pfkA, pdhA, ackA,
citZ, pyc, glmU, icaA, ldh1, alsS, cidA, ilvD, and RNAIII) after three and six hours of
growth (Fig. 12A-B). We observed consistent patterns with the RNA-seq data for
exponential-phase cells, including decreased expression of glycolytic genes across all
three mutants compared to the WT, with the exception of pfkA in the codY mutant (Fig.
12A). Furthermore, the codY and codY ccpA mutants demonstrated increased
expression of ilvD, which validates the increased amino acid biosynthesis genes seen in
the RNA-seq analysis. We also saw that the codY mutant had decreased expression of
citZ, the gene encoding the first enzyme of the TCA cycle, similar to the decreased
expression of the TCA cycle operon sucCD expression observed in the RNA-seq
analysis. The ccpA mutant, on the other hand, showed increased expression of citZ,
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Figure 12. Expression of various genes corroborates RNA-seq results. RTPCR was performed on the same mRNA samples collected for RNA-seq using
primers to analyze expression of key metabolic genes and RNAIII. Differences in
gene expression between each mutant and the WT after three hours of growth (A) or
six hours of growth (B) are shown.
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consistent with previous studies that have shown citZ to be repressed by CcpA (Fig.
12A) (195).
Using RT-PCR, we found changes in gene expression that were not identified in the
RNA-seq analysis. For example, RT-PCR analysis of icaA expression after three hours
of growth showed increased expression in the codY and codY ccpA mutants, in contrast
to the RNA-seq analysis that only showed a significant difference of icaA expression in
the codY mutant (Fig. 12A, data not shown). Additionally, although we did not detect any
significant changes in pyc expression in the RNA-seq analysis (data not shown), we
found an increased pyc expression in the codY and codY ccpA mutants, which was
consistent with a previous transcriptomics analysis (Fig. 12A) (185). Furthermore, we
detected lower gene expression of pyruvate fermentation pathway genes (ldh1, alsS,
cidA) in the ccpA and codY ccpA mutants using RT-PCR, also consistent with results
from a previous transcriptomic study (Fig. 12A) (185). There was also decreased pta
expression in the codY and codY ccpA mutants, but no changes in ackA expression in
any of the mutants. Seidl et al. did not observe any changes to pta or ackA expression in
a ccpA mutant (195), though Shivers et al. observed both CodY and CcpA are positive
regulators of ackA in B. subtilis (198). We also observed decreased glmU expression in
all strains, similar to the decrease in glycolytic gene expression (Fig. 12A). glmU is a key
enzyme in the synthesis of UDP-N-acetylglucosamine (UDP-GlcNAc), an important
precursor for cell wall synthesis and PIA production (210). In a subsequent section, we
will show that the decreased glmU expression does not impair PIA production in the
codY and codY ccpA mutants (Fig. 14A). Finally, in correlation with the RNA seq results,
RNAIII was overexpressed in the codY mutant compared to the WT (Fig. 12A). In
addition, RNAIII expression was strongly downregulated in the ccpA mutant. In
accordance with our findings that virulence genes are not overexpressed in a double
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codY ccpA mutant, we observed decreased RNAIII expression in the codY ccpA mutant,
verifying CcpA is required for activation of the agr system even if repression by CodY is
alleviated (Fig. 12A).
During the post-exponential phase of growth, the ccpA and codY ccpA mutants
shoed increased glycolytic gene expression (pgi, pfkA, pdhA), except for pfkA
expression in the ccpA mutant, which was slightly lower than WT (Fig. 12B). As
mentioned before, glucose is still available for these strains, so an increase in glycolytic
gene expression compared to the WT was expected (Fig. 9A). Similarly, we observed an
increase in ackA expression for both the ccpA and codY ccpA mutants, in contrast to the
RNA-seq data which suggested only the ccpA mutant had increased ackA expression
(Fig. 10B, Fig. 12B). Since glucose is exhausted for the WT by this point, the TCA cycle
is derepressed. Since part of CcpA’s role in carbon catabolite repression is to repress
the TCA cycle, one might expect TCA cycle gene expression to be similar between the
WT and the ccpA mutant during post-exponential phase of growth (191). However, we
observed decreased citZ expression in the ccpA and codY ccpA mutants compared to
the WT. These data would suggest that derepression of the TCA cycle through ccpA
inactivation is not as strong as derepression caused by exhaustion of glucose, indicating
the presence of one or more additional factors repressing the TCA cycle when glucose is
present.
As before, we see patterns emerge where the codY mutant phenotype is dominant in
the codY ccpA mutant as well as the opposite where the ccpA mutant phenotype is
dominant. Again, the codY mutant phenotype is dominant in amino acid biosynthesis
(ilvD) (Fig. 12B). However, now the ccpA mutant phenotype is dominant in expression of
glycolytic genes (pgi, pdhA), ackA, and RNAIII (Fig. 12B). Overall, the RT-PCR data
supported the findings of the global transcriptomic approach, where CcpA modulates
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carbon catabolite repression and virulence gene expression and CodY modulates amino
acid biosynthesis and virulence.

4.4 A metabolomic approach further elucidates pathways
disrupted by CodY and CcpA inactivation
Next, we evaluated disruption to global metabolism caused by inactivation of the
ccpA and codY genes by measuring intracellular metabolite concentrations after three
and six hours of growth using LC/MS-MS (Fig. 13A,B). Generally, the observed
differences between the mutants and UAMS-1 correlated with differences observed in
the transcriptomic analysis.
During the exponential phase of growth, the codY mutant had elevated
concentrations of intracellular amino acids, PPP intermediates, and nucleic acid
intermediates (Fig. 13A). Increased intracellular amino acid concentrations are
consistent with the increased expression of amino acid biosynthesis genes (Fig. 10A,
Fig. 13A). RNA seq revealed decreased expression of purine biosynthesis genes in the
codY mutant, yet here we observed increased concentrations of PPP intermediates and
nucleic acid intermediates (Fig. 10A, Fig. 13A). As mentioned before, lower ATP levels
in the codY mutant could explain the impairment of purine biosynthesis. Allosteric
feedback inhibition by increased AMP levels in the codY mutant could cause
downregulation of purine biosynthesis genes (240). The increased levels of purine
intermediates could be explained by overexpression of purine salvage genes, such as
xpt (data not shown).
Meanwhile, the ccpA mutant had increased concentrations of intracellular glycolytic
intermediates, ornithine, 6-phospho-D-gluconate, and hypoxanthine. Meanwhile, the
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Figure 13. Metabolomics further elucidates metabolic changes resulting from
codY and/or ccpA inactivation. (A) Fold-change differences greater than 2 at the
three-hour time point are shown, with metabolites roughly grouped by pathway. (B)
Fold-change differences greater than 2 at the six-hour time point are shown.
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ccpA mutant had decreased intracellular levels of amino acids, consistent with our other
data that suggest the ccpA mutant is consuming amino acids for growth during the
exponential phase (Fig. 9C, Fig. 10A, Fig. 13A). For the most part, the trends of
intracellular metabolite concentrations are similar between the ccpA and codY ccpA
mutants (Fig. 13A). In the case of the ccpA and codY ccpA mutants, it appears as if
there are specific blockages to certain pathways (PPP and purine biosynthesis), since
these highly concentrated metabolites lay at nodes connecting central metabolic
pathways and the other metabolites within those pathways show no change compared to
WT, indicating a direct transcriptional regulatory role for CcpA (Fig. 13A).
Interestingly, like the ccpA mutant where the TCA cycle is derepressed, the codY
mutant demonstrated a similar increase in citrate and succinate levels, despite
decreased expression of TCA cycle genes in the codY mutant (Fig. 10A, Fig. 13A). It’s
not yet clear what role CodY has in regulation of the TCA cycle. One possible
explanation could be that CodY is a direct or indirect activator of the TCA cycle. Without
it, TCA cycle metabolites accumulate due to blockages caused by a failure to activate
TCA cycle gene expression. In contrast, CcpA is a repressor of the TCA cycle and
alleviation of this repression results in increased flux through the TCA cycle (218).
Finally, ccpA and codY ccpA showed decreased concentrations of D-alanine-Dalanine, indicating a defect in cell wall biosynthesis (Fig. 13A). There was a concomitant
increase in D-glucosamine 6-phosphate concentrations in ccpA and codY ccpA, possibly
due to a block in cell wall biosynthesis as indicated by decreased D-alanine-D-alanine.
Inactivation of ccpA has been linked to cell wall alterations in previous studies (199,
241). The cell wall fraction of a ccpA mutant was compared with the wild-type S.
pneumoniae strain and the authors found many cell wall proteins were regulated, directly
or indirectly, by CcpA (241). Furthermore, another study showed that a deletion of ccpA
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in the S. aureus strain COLn caused a four-fold reduction in susceptibility to oxacillin, an
antibiotic that targets the cell wall (199). These findings, along with our own, suggest
CcpA plays a role in cell wall biosynthesis.
Altogether, our results have indicated CodY and CcpA are master regulators of both
metabolism and virulence gene expression during growth, all of which impacts the
optimal growth of the organism.

4.5 Disruption of carbon flow through ccpA inactivation has
only a minor effect on PIA production
Since inactivation of the codY gene is known to increase PIA biosynthesis through
overexpression of the ica operon (183), we asked if disruption of central metabolism
through ccpA inactivation resulted in decreased PIA biosynthesis. Earlier, in our RT-PCR
analysis, we discovered icaA gene expression was comparable between the codY and
codY ccpA mutants. However, carbon flow disruption could still impact the ability of the
double codY ccpA mutant to produce PIA, so we directly measured PIA production using
anti-PIA antibodies. As shown in Fig. 14A and 14B, there was only a slight reduction in
PIA production in the codY ccpA mutant compared to the codY mutant. Notably, the
production of PIA in the codY ccpA mutant was still very high compared to the WT or
ccpA mutant, indicating this overproduction of PIA by the codY ccpA mutant could result
in a similar biofilm phenotype to the codY mutant.
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Figure 14. The codY and codY ccpA mutants overproduce PIA. Using antiPIA antibodies, we detected PIA production by each strain after three or six hours of
growth. Relative fold-change differences between each mutant and the WT are
shown in (A) and the immunoblot used to quantify these differences is shown in (B).
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4.6 Disruption of metabolic regulation alters biofilm matrix
production and biofilm morphology
Finally, we tested the ability of these strains to form biofilms and the effect of codY
and ccpA inactivation on biofilm matrix production. The codY mutation has been shown
to cause the cells to form a biofilm with a matrix consisting of PIA and eDNA, with very
“stringy” structures (68). Consistent with this, the biofilms formed by this mutant stained
strongly with TOTO-1, a fluorescent probe that indicates the presence of eDNA and
dead cells (242). After 6 hours of biofilm growth in a constant flow environment, we
added matrix-degrading agents to test the biofilm matrix composition (Fig. 15). To
disrupt proteins in the matrix, we added Proteinase K, which completely disrupted the
UAMS-1 and ccpA mutant biofilms, whereas the codY and codY ccpA mutant biofilms
remained relatively intact, with only the basal layer of cells being disrupted. The
remaining biofilm cells were associated with the long “stringy” structures previously
described (68). These remaining structures were presumably held intact by the
increased levels of PIA as a result of codY inactivation. In contrast, DNase I treatment
did not have a drastic effect on the basal layer of the biofilms formed by any strain but
disrupted the “stringy” structures formed by the codY mutant, indicating the presence of
eDNA in these structures. Interestingly, the codY mutant overexpresses nuc, which
encodes a secreted nuclease that degrades matrix eDNA and is involved in the “exodus”
phase of biofilm development (25). In agreement with the low eDNA staining, the codY
ccpA mutant biofilm “strings” were not disrupted by DNase I treatment, presumably
because they are held intact by PIA. Next, we used sodium metaperiodate to degrade
matrix-associated PIA. As shown in Fig. 15, the “stringy” structures produced by the
codY and codY ccpA mutant biofilms were disrupted by metaperiodate, indicating PIA is
a major structural component for these structures.
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Figure 15. Metabolic regulation is critical for proper biofilm development.
Each quadrant shows how each strain (WT, codY, ccpA, and codY ccpA) forms a
biofilm in untreated conditions or when exposed to treatment with a matrix-degrading
agent [Proteinase K (100 μg ml-1), DNase I (10 U ml-1), or sodium metaperiodate (2
mM)]. To further determine matrix production, we stained the biofilms with TOTO-1,
which fluoresces green when it interacts with eDNA or dead cells.
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Overall, the biofilm matrix produced by UAMS-1 likely consists of PIA, eDNA, and
proteins, with proteins being the most crucial matrix component. In the codY mutant, the
basal biofilm layer attaches through protein-substrate interactions and the “stringy”
structures produced by the codY mutant are held together by PIA and eDNA. The ccpA
mutant incorporates relatively little eDNA compared with all other strains, and with most
of the matrix composition being proteins. The codY ccpA mutant exhibits an intermediate
biofilm that incorporates relatively little eDNA in its matrix, the basal layer attaches via
proteins, and the “stringy” structures are held together by PIA (but not eDNA, in contrast
to the codY mutant). Clearly, metabolic regulation by CodY and CcpA are important for
the development of a healthy, structured biofilm.

4.7 Discussion
Carbon catabolite repression (CCR) is well-conserved among bacteria, common to
both Gram negative and Gram positive bacteria (243). In Gram positive bacteria, the
transcriptional regulator CcpA, along with other components of CCR (HPr, HPrK, PTS),
mediates the connection between environmental input (availability of glucose) and
transcription of genes involved in consumption of glucose or secondary carbon sources
(191). Additionally, another transcriptional regulator, CodY, modulates the production of
toxins, amino acids, and biofilm matrix components like PIA (186). CodY is also sensitive
to environmental input, as low concentrations of GTP or isoleucine causes CodY to lose
its affinity for DNA in a step-wise fashion, allowing for de-repression of toxin, amino acid,
and PIA biosynthesis (183). Together, these regulators must work to sense the
environment and transduce those signals to modulate gene expression in the cell that
allows for optimal growth and/or survival.
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In this study, we found that inactivation of the codY and ccpA genes can drastically
change expression of genes involved in central metabolism and virulence (Fig. 10A,B).
Our findings confirm WT S. aureus preferentially consumes glucose to produce acetate
(Fig. 9A,B) during the exponential phase of growth, producing ATP through substrate
level phosphorylation and recycling NAD+ through the electron transport chain (ETC).
When CcpA is inactivated, glucose consumption decreases while consumption of
secondary carbon sources, such as amino acids and acetate, increases (Fig. 9A, Fig.
10A, Fig. 13A, data not shown). Inactivation of codY has small impact on growth during
the exponential phase, with a slight reduction in acetate production (Fig. 9B) and
increased amino acid biosynthesis (Fig. 10A). The double codY ccpA mutant grew
similarly to the ccpA mutant, with increased consumption of secondary carbon sources
and decreased glycolysis (Fig. 8A, Fig. 9A,B, Fig. 10A,B), but also exhibited increased
amino acid biosynthesis like the codY mutant (Fig. 10A,B).
Another interesting finding was that CcpA is seemingly required for activation of the
agr system (Fig. 12A,B, data not shown). Even though codY inactivation derepresses
the agr system and causes overexpression of virulence factors, inactivation of ccpA was
the dominant phenotype in the double codY ccpA mutant. In the ccpA mutant, we
observed a strong decrease in expression of the agr system effector molecule, RNAIII,
which stayed consistent in the codY ccpA mutant (Fig. 12A,B). This interplay for control
of the expression of this major virulence regulator (agr) highlights the complexity and
importance of gene regulation within S. aureus and how the regulators interact in ways
to fine-tune expression of critical genes such as those encoding virulence factors.
Finally, we demonstrated that these regulators are important for the proper
development of mature biofilm structures. Wild-type UAMS-1 forms highly structured
biofilms containing various niches with unique morphologies, including differences in
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gene expression and matrix composition, which are completely susceptible to Proteinase
K treatment (Fig. 15, (25, 74)). In contrast, the codY mutant is known to make “stringy”
biofilm structures held together by increased amounts of PIA and eDNA (68). In these
experiments, we observed the ccpA mutant biofilms incorporate less eDNA into the
matrix. In a double codY ccpA mutant biofilm, “stringy” biofilm structures are still formed
but they incorporate less eDNA, as evidenced by the recalcitrance of these structures to
DNase I treatment (Fig. 15). Proper regulation of metabolism and biofilm-related genes
by CodY and CcpA is critical for biofilm development, as inactivation of either or both
regulators drastically change the structure and composition of S. aureus biofilms.
Though this study shed light on the interaction between CodY and CcpA in regulating
central metabolism, virulence, and biofilm development, there is much to be learned
about the complex interactions between these regulators and the roles they play during
infection.

5 Discussion and Future Directions
Biofilm development is an intricately complicated process that is largely conserved
among different bacterial species. Most species will attach to a surface, build an
extracellular matrix and multiply, then partially degrade the matrix and disperse a
subpopulation to colonize elsewhere. The molecular components used to mediate each
stage differs among species, but some common features remain. Each species uses a
combination of eDNA, polysaccharides, and/or proteins to form the biofilm matrix. The
architecture provided by the matrix allows for the bacteria to form large structures, within
which metabolically distinct microenvironments can form. From these microenvironments
emerge heterogeneous gene expression, matrix production, and antibiotic susceptibility.
However, observations in P. aeruginosa and S. aureus indicate physiological
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heterogeneity is established well before any obvious microenvironment has a chance to
form, indicating heterogeneity is a part of the developmental process and not just the
byproduct of microenvironmental cues (24, 74, 112). Furthermore, the ubiquity of
physiological heterogeneity among bacterial species implies that this behavior serves
important functions. Thus, understanding the mechanisms behind physiological
heterogeneity can help us develop better treatments for biofilm infections. Based on the
data gathered to date, it seems clear that biofilm heterogeneity arises as a function of
both microenvironmental and genetic factors. While the former can be predicted based
on our knowledge of the response of bacteria to environmental signaling, the latter has
eluded detection until relatively recently.
If some aspects of biofilm heterogeneity have a genetic basis, then what are the
forces that underlie selection for these processes? One possibility is as a mechanism to
conserve energy, whereby selected individuals make a shared product for the common
good of the entire population. Examples of this are the division of labor for the production
of the TasA protein and EPS matrix components in B. subtilis (19), or virulence factor
expression by S. aureus (109). In both examples, key stages of biofilm development are
(or are suspected to be) under the control of bistable switches that generate a
heterogeneous response.
Another driving force selecting for heterogeneous expression are the benefits of a
bet hedging strategy to prepare for an uncertain future. As mentioned above, persisters
are frequently observed in biofilms (39). As is the case for adhesion and matrix
production, antibiotic tolerance is under the control of bistable switches, likely as a
means to prepare the population for unanticipated environmental threats. The presence
of these persister cells allows the population to survive until either the community adapts
their gene expression to the new conditions, or the adverse conditions improve. A
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physiologically diverse biofilm can better withstand changing environmental stresses,
such as nutrient limitation or the presence of antibiotics, similar to how a diverse forest
can better withstand droughts and disease (244).
Future studies are sure to find more examples of bistable switches regulating the
development and survival of biofilms. Physiological heterogeneity provides the biofilm
population with the ability to survive stressful situations, giving rise to a formidable foe
already adapted to our current methods of treatment. In the experiments described in
this dissertation, we demonstrated that metabolic heterogeneity can arise stochastically
before nutrient gradients can be established. Furthermore, we showed that metabolic
regulation by CodY and CcpA are critical to the proper development of a mature biofilm,
with control over the production of virulence factors and biofilm matrix components. In
the future, we will investigate if physiological heterogeneity is disrupted by inactivation of
metabolic regulators. We will utilize our gene reporter fusion approach to ask whether
metabolic regulation plays a role in the establishment of metabolically distinct niches
during S. aureus biofilm development.
Despite many advances in our understanding of biofilms, we are still just scratching
the surface into the mechanisms underlying biofilm development and physiological
heterogeneity. Armed with a better understanding of these mechanisms we will be better
able to develop more informed therapeutic strategies to treat biofilm-associated
infections.
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